$SLGN

SILGAN HOLDINGS INC

0
0
2

No SEC Form 4 filings for $SLGN in the last 30 days.

See all $SLGN insider activity →
Med

SLGN Maintained by UBS -- Price Target Lowered to $38

UBS analyst Anoja Shah maintained a Neutral rating on Silgan Holdings (SLGN) but lowered the price target from $47 to $38, citing potential challenges. GuruFocus values SLGN at $52, suggesting a 32.7% undervaluation. The company has a GF Score of 81/100, with strengths in profitability and valuation but weaknesses in financial strength.

SLGN sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning SLGN (SILGAN HOLDINGS INC). Coverage has skewed bearish: 0 bullish, 0 neutral, and 2 bearish.

Recent SLGN coverage spans financial news, earnings and market movers.

What's driving SLGN

AlphAI scores every news story that mentions SLGN with an AI model for sentiment and relevance, and aggregates insider trades from SILGAN HOLDINGS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $SLGN

Score

SLGN Maintained by UBS -- Price Target Lowered to $38

UBS analyst Anoja Shah maintained a Neutral rating on Silgan Holdings (SLGN) but lowered the price target from $47 to $38, citing potential challenges. GuruFocus values SLGN at $52, suggesting a 32.7% undervaluation. The company has a GF Score of 81/100, with strengths in profitability and valuation but weaknesses in financial strength.

Q2 Earnings Review: Industrial Packaging Stocks Led by Avery Dennison (NYSE:AVY)

Packaging Corporation of America (PCA) reported Q2 revenue of $2.49B, up 14.7% YoY, but missed EPS estimates. International Paper (IP) reported $6.00B revenue, down 11.3% YoY, missing expectations. Silgan Holdings (SLGN) reported $1.64B revenue, up 6.8% YoY, beating estimates. PCA and SLGN stocks are up 1.9% and down 19.7% since reporting, respectively. IP stock is down 18.1% since reporting.

SILGAN HOLDINGS INC (SLGN): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

SILGAN HOLDINGS INC (SLGN) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 2, 2026, Silgan Holdings Inc., or the Company, and Philippe Chevrier, the Executive Vice President and Chief O

$SLGNMed

Silgan Holdings (SLGN) Beat Expectations, Is The Stock Still Undervalued?

Silgan Holdings (SLGN) reported Q2 2026 adjusted earnings of $0.98 per share, beating estimates and reaffirming full-year guidance. The stock is at $42.10, up 12.09% over 90 days but down 8.47% over one year. Analysts suggest it may be undervalued at $42.10 vs. a fair value estimate of $54.77, citing sustainability trends and margin expansion potential, but note risks including reliance on legacy formats and concentrated customers.

$SLGNMed

What Silgan Holdings (SLGN)'s Dividend Hike and Segment Upgrade Mean For Shareholders

Silgan Holdings (SLGN) declared a quarterly cash dividend of $0.21 per share, payable Sept. 15, 2026, to shareholders of record Sept. 1, extending annual increases for 90 consecutive quarters since 2004. RBC Capital Markets upgraded the stock, citing momentum in Silgan’s Dispensing and Specialty Closures segment. The article cites 2029 targets of $7.3B revenue and $441.7M earnings.

$SLGNMed

Why Silgan Holdings (SLGN) Stock Is Up Today

Silgan Holdings (NYSE:SLGN) shares rose 3.6% to close at $42.15 after RBC Capital Markets upgraded the stock to “Outperform” from “Sector Perform” and raised its price target to $58. RBC cited positive momentum in the Dispensing and Specialty Closures segment, which accounts for 42% of fiscal 2025 sales and about half of EBIT.

Why Silgan Holdings (SLGN) Stock Is Up Today

Silgan Holdings (NYSE: SLGN) shares rose 3.6% to $42.15 after RBC Capital Markets upgraded the stock to “Outperform” from “Sector Perform” and raised its price target to $58. RBC cited positive momentum in the Dispensing and Specialty Closures segment, which accounts for 42% of fiscal 2025 sales and about half of EBIT.

Related tickers